INDV Stock Recent News

NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=94379&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Indivior PLC (“Indivior”) (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”). For more information, submit a form at Indivior PLC Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030.

Indivior PLC (NASDAQ:INDV ) Q2 2024 Earnings Conference Call July 25, 2024 8:30 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Christian Heidbreder - Chief Scientific Officer Ryan Preblick - CFO Conference Call Participants David Amsellem - Piper Sandler Paul Cudden - Deutsche Numis Chase Knickerbocker - Craig-Hallum Thibault Boutherin - Morgan Stanley Max Herrmann - Stifel Operator Good day, and thank you for standing by. Welcome to the Indivior PLC Half Year Results 2024 Conference Call and Webcast.

Indivior PLC (INDV) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.40 per share a year ago.

London-listed pharmaceuticals company Indivior PLC (LSE:INDV) has, as anticipated, confirmed that it will move its primary listing to the US. Shareholders still need to approve the transfer, though this will be seen as a formality given the previously signalled support from major shareholders.